Betzemeier; Bodo
Patent Applications and Registrations
Patent applications and USPTO patent grants for Betzemeier; Bodo.The latest application filed is for "crystalline salts of a b-raf kinase inhibitor".
- Betzemeier; Bodo - Ingelheim am Rhein DE
- BETZEMEIER; Bodo - Biberach an der Riss DE
- Betzemeier; Bodo - Biberach DE
- Betzemeier; Bodo - Bad Fischau AT
- Betzemeier; Bodo - Vienna AT
| Patent | Date |
|---|---|
| Crystalline Salts Of A B-raf Kinase Inhibitor App 20220204506 - Werthmann; Ulrike ; et al. | 2022-06-30 |
| Crystalline salts of a B-RAF kinase inhibitor Grant 11,306,086 - Werthmann , et al. April 19, 2 | 2022-04-19 |
| Medical Use Of Compound Iii App 20210130362 - SAND; Michael Steven ; et al. | 2021-05-06 |
| Medical use of compound III Grant 10,919,898 - Sand , et al. February 16, 2 | 2021-02-16 |
| Crystalline Salts Of A B-raf Kinase Inhibitor App 20200283433 - Werthmann; Ulrike ; et al. | 2020-09-10 |
| Medical Use of Compound III App 20180237445 - SAND; Michael Steven ; et al. | 2018-08-23 |
| Pyrimidine derivatives that inhibit FAK/PTK2 Grant 8,785,464 - Stadtmueller , et al. July 22, 2 | 2014-07-22 |
| New Compounds App 20140038993 - STADTMUELLER; Heinz ; et al. | 2014-02-06 |
| Crystalline Form Of A Indolinone Derivative And Its Use App 20140018372 - MAIER; Gerd-Michael ; et al. | 2014-01-16 |
| 2,4-diaminopyrimidine derivates as PTK2-inhibitors for the treatment of abnormal cell growth Grant 8,377,943 - Sapountzis , et al. February 19, 2 | 2013-02-19 |
| Substituted indolines as tyrosine kinase inhibitors Grant 8,207,179 - Engelhardt , et al. June 26, 2 | 2012-06-26 |
| Thiazolyl-dihydro-indazoles Grant 8,207,349 - Betzemeier , et al. June 26, 2 | 2012-06-26 |
| New Compounds App 20110288109 - Stadtmueller; Heinz ; et al. | 2011-11-24 |
| 2,4-diaminopyrimidine Derivates As Ptk2- Inhibitors For The Treatment Of Abnormal Cell Growth App 20110275633 - Sapountzis; Ioannis ; et al. | 2011-11-10 |
| Thiazolyl-dihydro-indazole Grant 7,902,183 - Steurer , et al. March 8, 2 | 2011-03-08 |
| Thiazolyl-dihydro-indazole Grant 7,893,049 - McConnell , et al. February 22, 2 | 2011-02-22 |
| New Compounds App 20100222331 - Engelhardt; Harald ; et al. | 2010-09-02 |
| Thiazolyl-dihydro-indazoles App 20100113414 - BETZEMEIER; Bodo ; et al. | 2010-05-06 |
| Thiazolyl-dihydro-indazole Grant 7,691,888 - Betzemeier , et al. April 6, 2 | 2010-04-06 |
| Thiazolyl-Dihydro-Indazole App 20080081802 - MCCONNELL; Darryl ; et al. | 2008-04-03 |
| Thiazolyl-Dihydro-Indazole App 20070270401 - STEURER; Steffen ; et al. | 2007-11-22 |
| Indolinones And Their Use As Antiproliferative Agents App 20070088051 - McConnell; Darryl ; et al. | 2007-04-19 |
| Indolinones and their use as antiproliferative agents App 20060135592 - McConnell; Darryl ; et al. | 2006-06-22 |
| Thiazolyl-dihydro-indazole App 20060100254 - Betzemeier; Bodo ; et al. | 2006-05-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 